Edition:
Deutschland

Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,690JPY
05:46 Uhr
Change (% chg)

¥10 (+0.63%)
Prev Close
¥1,679
Open
¥1,718
Day's High
¥1,736
Day's Low
¥1,686
Volume
3,465,700
Avg. Vol
6,902,131
52-wk High
¥2,056
52-wk Low
¥1,380

4503.T

Chart for 4503.T

About

Astellas Pharma Inc. is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company is involved in the manufacture and sale of pharmaceutical products in Japan, the United States, Europe, China, Korea, Taiwan and other markets through its subsidiaries. Its main... (more)

Buy/Sell

Sell Hold Buy
2.85 Mean rating from 13 analysts

Overall

Beta: 0.60
Market Cap(Mil.): ¥3,012,207.00
Shares Outstanding(Mil.): 2,068.82
Dividend: 18.00
Yield (%): 2.34

Pfizer, Astellas revise two cancer drug trial protocols to speed up results

Aug 22 Drugmakers Pfizer Inc and Astellas Pharma Inc said on Wednesday they would change protocols for two late-stage trials testing prostate cancer drug Xtandi to speed up completion.

Nikkei edges up in choppy trade but gains limited as trade war weighs

* Market cautious before Japan-U.S. bilateral talks this week

Nikkei ends near 1-month low as trade war concerns sour mood

TOKYO, June 28 Japan's Nikkei ended flat but near one-month lows on Thursday, taking its cue from weakness on Wall Street as a simmering trade row between the United States and China hurt investor risk appetite.

Nikkei hits near 1-month low; large caps weak as trade war fears take toll

TOKYO, June 28 Japanese stocks dropped to near one-month lows on Thursday morning, taking their cue from weakness on Wall Street overnight as the simmering trade row between the United States and China hurt investors' risk appetites.

UPDATE 2-Aquinox to stop development of lead drug; shares plunge

June 27 Aquinox Pharmaceuticals Inc said on Wednesday it planned to stop developing its main drug to treat bladder pain syndrome as it failed to meet the main goal of a late-stage trial, pushing its shares down as much as 85 percent.

Nikkei rises after ECB, looks past BOJ to focus on trade woes

TOKYO, June 15 Japan's Nikkei share average rose on Friday after the European Central Bank announced it would avoid raising rates until mid-2019, but chip-related stocks tumbled as a brokerage slashed the target price of Tokyo Electron.

Nikkei rises after ECB's decision; chip-related shares tumble

TOKYO, June 15 Japan's Nikkei share average rose on Friday morning after the European Central Bank announced it would avoid raising rates until mid-2019, but chip-related stocks tumbled after a brokerage slashed the target price of Tokyo Electron.

Nikkei rises but gains limited before U.S.-N.Korea summit

TOKYO, June 11 Japanese stocks rose on Monday but gains were limited as investors focused on the U.S.-North Korea summit, while Tokyo Electric soared as the outcome of a local election was seen to be positive for one of the utility's nuclear power plants.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie +0.18%
Rohstoffe -0.07%
Industrie +0.06%
Konjunktur abhängige Waren & Dienstleistungen +0.04%
Konjunktur unabhängige Waren & Dienstleistungen +0.06%
Finanzindustrie -0.02%
Pharma -0.01%
Technologie +0.26%
Telekommunikation +0.18%